AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 62 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,019,866 | +564.0% | 335,777 | +265.8% | 0.00% | – |
| Q3 2022 | $756,000 | +28.6% | 91,802 | +2.5% | 0.00% | – |
| Q2 2022 | $588,000 | -11.6% | 89,600 | -24.6% | 0.00% | – |
| Q1 2022 | $665,000 | -38.8% | 118,800 | -48.7% | 0.00% | – |
| Q4 2021 | $1,087,000 | +21.3% | 231,627 | +59.7% | 0.00% | – |
| Q3 2021 | $896,000 | +18.1% | 145,035 | +25.9% | 0.00% | – |
| Q2 2021 | $759,000 | -59.5% | 115,200 | -55.0% | 0.00% | – |
| Q1 2021 | $1,872,000 | +138.2% | 255,769 | +87.9% | 0.00% | – |
| Q4 2020 | $786,000 | -11.2% | 136,122 | -8.7% | 0.00% | – |
| Q3 2020 | $885,000 | -64.8% | 149,126 | -69.5% | 0.00% | -100.0% |
| Q2 2020 | $2,516,000 | +1710.1% | 488,603 | +1169.7% | 0.00% | – |
| Q1 2020 | $139,000 | – | 38,483 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PATHWAY CAPITAL MANAGEMENT, LP | 245,606 | $3,671,810 | 6.55% |
| AIGH Capital Management LLC | 695,358 | $10,395,602 | 3.42% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 638,360 | $9,544 | 2.08% |
| Kellner Capital, LLC | 100,016 | $1,495 | 1.74% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,464,807 | $21,898,865 | 1.70% |
| Worth Venture Partners, LLC | 170,925 | $2,555,329 | 1.51% |
| Birchview Capital, LP | 100,000 | $1,495 | 1.06% |
| BCK CAPITAL MANAGEMENT LP | 68,000 | $1,016,600 | 1.05% |
| WATER ISLAND CAPITAL LLC | 698,915 | $10,449 | 0.89% |
| EHP Funds Inc. | 292,043 | $4,366 | 0.82% |